Table 1.
Patient characteristics
| Baseline demographics | N (%) or mean ± SD |
|---|---|
| Gender (male) | 62 (63%) |
| Age (years) | 69 ± 12.9 |
| Body mass (kg) | 82.4 ± 17.3 |
| Height (cm) | 169.4 ± 9.0 |
| Body mass index | 28.7 ± 5.4 |
| Medical history | |
| Nicotinism (history) | 47 (48%) |
| Diabetes mellitus | 40 (40.8%) |
| Hypertension | 72 (73.4%) |
| Dyslipidaemia | 72 (73.4%) |
| Chronic kidney disease | 25 (25.5%) |
| eGFR | 68.5 ± 21 |
| Thyroid dysfunction | 19 (19.4%) |
| Hypothyroidism | 15 (15.3%) |
| Hyperthyroidism | 4 (4.1%) |
| Asthma | 4 (4.1%) |
| Chronic obstructive pulmonary disease | 9 (9.2%) |
| Cardiovascular history: | |
| Stable angina (angina pectoris) | 31 (31.6%) |
| ACS (admission) | 15 (15.3%) |
| Myocardial infarction (history) | 31 (31.6%) |
| PCI/CABG (history) | 41 (41.8%) |
| Heart failure | 55 (56.1%) |
| NYHA II | 30 (30.6%) |
| NYHA III | 22 (22.4%) |
| NYHA IV | 3 (3.1%) |
| LVEF (%) | 49.7 ± 12.6 |
| Atrial fibrillation | 43 (43.9%) |
| Paroxysmal | 17 (17.3%) |
| Persistent | 12 (12.2%) |
| Chronic | 14 (14.3%) |
| CIED implanted | 34 (34.7%) |
| Pacemaker | 22 (22.4%) |
| AAI | 1 (1.0%) |
| VVI | 10 (10.2%) |
| DDD | 11 (11.2%) |
| ICD | 9 (9.2%) |
| CRT | 3 (3.1%) |
| Ablation | 6 (6.1%) |
ACS, acute coronary syndrome; CABG, coronary artery bypass graft; CIED, cardiac implantable electronic devices; CRT, cardiac resynchronization; eGFR, estimated glomerular filtration rate; ICD, implantable cardioverter-defibrillator; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; PCI, percutaneous coronary intervention.